PTGS2 and neoplasm: By inhibiting COX-2, an enzyme that promotes angiogenesis by increasing the expression of proangiogenic growth factors, like VEGF, in addition to inducing cell cycle arrest and DNA damage, the tumor environment can be targeted through two separate mechanisms.